Skip to main content
. Author manuscript; available in PMC: 2020 Jul 19.
Published in final edited form as: Med Clin North Am. 2017 Jul;101(4):769–785. doi: 10.1016/j.mcna.2017.03.008

Table 5.

Incremental cost-effectiveness lung cancer screening by National Lung Screening Trial subgroup

Characteristics Number of participants Incremental costs (U.S. $) Incremental QALYs Cost per QALY (U.S. $)
Sex Male 31,446 1,683 0.0115 147,000
Female 21,856 1,557 0.0340 46,000
Age at entry 55–59 22,773 1,541 0.0101 152,000
60–64 16,333 1,520 0.0320 48,000
65–69 9,504 1,900 0.0351 54,000
70–74 4,685 1,905 0.0163 117,000
Smoking status Former 27,643 1,661 0.0027 615,000
Current 25,659 1,601 0.0369 43,000
Risk of lung cancer First quintile 10,660 1,453 0.0086 169,000
Second quintile 10,661 1,454 0.0118 123,000
Third quintile 10,660 1,651 0.0061 269,000
Fourth quintile 10,661 1,672 0.0515 32,000
Fifth quintile 10,660 1,851 0.0354 52,000

Abbreviations: QALY = quality-adjusted life year

Data from Black WC, et al. New Engl J Med 2014:371:1793